FDA Adverse Event Malfunction Summary report: N

OPTIPAC-S 40 REFOBACIN BONE CEMENT R

MDR report key: 7302105 · Received February 28, 2018

Report

Report Number
3006946279-2018-00089
Event Type
Malfunction
Date Received
February 28, 2018
Date of Event
January 29, 2018
Report Date
January 16, 2019
Manufacturer
BIOMET FRANCE S.A.R.L.
Product Code
MBB
PMA / PMN Number
PK150850
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

(B)(4). THE DEVICE WAS NOT RETURNED TO THE MANUFACTURER. THEREFORE IT COULD NOT BE ANALYZED. THE DEVICE MANUFACTURING QUALITY RECORD INDICATES THAT THE RELEASED PRODUCT MET ALL REQUIREMENTS TO PERFORM AS INTENDED. THE ROOT CAUSE IS UNDETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

PLEASE REFER TO REPORT 3006946279-2018-00089-1.

Additional Manufacturer Narrative · 1

(B)(4). THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). REPORT SOURCE, FOREIGN - EVENT OCCURRED IN (B)(6). THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. PRODUCT NOT RETURNED TO MANUFACTURER.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING PREPARATION OF THE BONE CEMENT, THE MONOMER LIQUID WOULD NOT DISPENSE INTO THE CYLINDER. ANOTHER ARTICLE HAS BEEN USED TO FINISH THE SURGERY. NO DELAY IN THE SURGERY WAS CAUSED BY THE ISSUE.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING PREPARATION OF THE BONE CEMENT, THE MONOMER LIQUID WOULD NOT DISPENSE INTO THE CYLINDER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
148068 OPTIPAC-S 40 REFOBACIN BONE CEMENT R BONE CEMENT, ANTIBIOTIC MBB BIOMET FRANCE S.A.R.L. A714A06350

Patients

Seq Age Sex Outcome Treatment
1